Form 4: YD Bio Director Receives Stock Grant
Insider Transaction (Form 4)
Shao-Ta Lu, a Director of YD Bio Ltd, reported multiple transactions in common stock on September 30, 2026.
Summary
- Option exercise/conversion: acquired 3,135 Ordinary Shares on September 30, 2026; holds 10,965 after (Direct).
- Grant/award: acquired 3,135 Restricted Share Units on September 30, 2026; holds 3,135 after (Direct).
- Option exercise/conversion: disposed of 3,135 Restricted Share Units on September 30, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Shao-Ta Lu — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-30 | Option exercise/conversion | Ordinary Shares | 3,135 | — | — | 10,965 |
| 2026-09-30 | Grant/award | Restricted Share Units | 3,135 | — | — | 3,135 |
| 2026-09-30 | Option exercise/conversion | Restricted Share Units | 3,135 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-30 | Option exercise/conversion (3,135 shares) |
| 2026-09-30 | Grant/award (3,135 shares) |
| 2026-09-30 | Option exercise/conversion (3,135 shares) |
Keywords
insider transaction, Form 4, YDES, YD Bio Ltd, neutral, Shao-Ta Lu
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.